Ledger. Australian venture funding, tracked

Company

Stragen International N.V.

Coverage

Stories naming Stragen International N.V.. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Venture debt ≤$15m

ChemGenex Announces Convertible Note Issue and Welcomes Cephalon, Inc. as a Substantial Investor

ChemGenex has signed a convertible note deal giving Cephalon up to A$15 million in notes, plus options over 19.9 percent of shares held by Stragen and Merck; major shareholders back the issue.

GBS Ventures 22 Oct 2010 ChemgenexAlta PartnersCephalon International Holdings, Inc.GBS Venture Partners Ltd.Merck Santé S.A.S.Stragen International N.V.Cephalon, Inc.Dr Greg Collier

Also GBS Ventures

Something wrong? Tell us